Monogram

Results: 142



#Item
111LabCorp Service Announcement LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection. As a specialty provider of HCV

LabCorp Service Announcement LabCorp Launches Interleukin 28B Polymorphism (IL28B) Genotype Test to Support Individualized Treatment Decisions for Patients with Hepatitis C Viral Infection. As a specialty provider of HCV

Add to Reading List

Source URL: www.svaproject.org

Language: English - Date: 2011-11-21 14:16:19
112ZET2SM  GE Monogram® 30

ZET2SM GE Monogram® 30" Built-In Double Oven ZET2SMSS

Add to Reading List

Source URL: products.geappliances.com

Language: English - Date: 2015-02-06 08:19:20
113[removed]August[removed]LABORATORY BULLETIN Bulletin # [removed]To: Northern Alberta Adult and Pediatric ID Physicians, HIV Nurses & Pharmacists

[removed]August[removed]LABORATORY BULLETIN Bulletin # [removed]To: Northern Alberta Adult and Pediatric ID Physicians, HIV Nurses & Pharmacists

Add to Reading List

Source URL: www.provlab.ab.ca

Language: English - Date: 2008-08-13 14:41:18
114FDA/FCHR Collaborative Public Meeting on Long-term Safety Concerns Associated with CCR5 Antagonist Development May 31, 2006 DRAFT REPORT Written by John Fry; Edited by Veronica Miller, on behalf of all presenters and pan

FDA/FCHR Collaborative Public Meeting on Long-term Safety Concerns Associated with CCR5 Antagonist Development May 31, 2006 DRAFT REPORT Written by John Fry; Edited by Veronica Miller, on behalf of all presenters and pan

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-04-20 08:28:23
115BCCLA-Monogram-Shadows-Gray

BCCLA-Monogram-Shadows-Gray

Add to Reading List

Source URL: bccla.org

Language: English - Date: 2013-09-25 18:44:57
116Buprenorphine in the HIV Primary Care Setting

Buprenorphine in the HIV Primary Care Setting

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-05-01 12:40:36
117Effectiveness of Telaprevir in HIV/HCV Co-infected Patients

Effectiveness of Telaprevir in HIV/HCV Co-infected Patients

Add to Reading List

Source URL: www.iapac.org

Language: English - Date: 2013-04-03 01:32:03
118Differential Impact of Non-adherence on Week 96 Outcomes in the FTC/TDF Subset of Pooled ECHO and THRIVE Studies Comparing Rilpivirine (RPV) vs. Efavirenz (EFV) in Treatment-naïve, HIV-1 Infected Adults D. Jayaweera1, R

Differential Impact of Non-adherence on Week 96 Outcomes in the FTC/TDF Subset of Pooled ECHO and THRIVE Studies Comparing Rilpivirine (RPV) vs. Efavirenz (EFV) in Treatment-naïve, HIV-1 Infected Adults D. Jayaweera1, R

Add to Reading List

Source URL: www.iapac.org

Language: English - Date: 2013-04-03 01:39:23
119Poster MOPE146 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, Italy, [removed]July 2011 A global non-profit initiative against HIV drug resistance www.hivrdi.org email: [removed]

Poster MOPE146 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, Italy, [removed]July 2011 A global non-profit initiative against HIV drug resistance www.hivrdi.org email: [removed]

Add to Reading List

Source URL: www.hivrdi.org

Language: English - Date: 2012-09-28 07:36:37
120Poster 39 International Workshop on HIV & Hepatitis Drug Resistance and Curative Strategies; 7-10 June 2011; Los Cabos, Mexico A global non-profit initiative against HIV drug resistance www.hivrdi.org  email: info@hivrdi

Poster 39 International Workshop on HIV & Hepatitis Drug Resistance and Curative Strategies; 7-10 June 2011; Los Cabos, Mexico A global non-profit initiative against HIV drug resistance www.hivrdi.org email: info@hivrdi

Add to Reading List

Source URL: www.hivrdi.org

Language: English - Date: 2012-09-28 07:38:14